Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22123848

COc1ccc(-c2cnc3c(Nc4ccc(C(=O)NCCOCCN(C)C)c(Cl)c4)nccn23)c(F)c1F.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 2/20 0.38
▸ CSF1R P07333 1/20 0.35
▸ IGF1R P08069 1/20 0.34
▸ CDK2 P24941 3/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ FGFR3 P22607 2/20 0.34
▸ ALK Q9UM73 2/20 0.34
▸ EGFR P00533 2/20 0.33
▸ TTK P33981 2/20 0.33
▸ LRRK2 Q5S007 1/20 0.32
▸ MCHR1 Q99705 1/20 0.32
▸ BRAF P15056 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22123511 0.96 PTK6 (0.41) PTK6CSF1RIGF1RCDK2CCNT1
SCHEMBL22124749 0.88 CDK2 (0.36) PTK6IGF1RCDK2CCNT1CCNA2
SCHEMBL22124604 0.88 PTK6 (0.41) PTK6CSF1RIGF1REGFRLRRK2
SCHEMBL30171566 0.88 PTK6 (0.41) PTK6CSF1RIGF1REGFRLRRK2
Trifluoroacetic Acid SCHEMBL30349560 0.86 SYK (0.36) PTK6TTKMCHR1BRAF
SCHEMBL25443967 0.85 CCNT1 (0.45) CDK2CCNT1CCNA2CDK9ALK
SCHEMBL24112398 0.85 PTK6 (0.44) PTK6IGF1RTTKMCHR1KDR
Trifluoroacetic Acid SCHEMBL30386106 0.85 PTK6 (0.47) PTK6EGFRTTKBRAF
SCHEMBL24112594 0.84 PTK6 (0.41) PTK6CSF1RIGF1RALKMCHR1
SCHEMBL22124828 0.84 TTK (0.32) PTK6IGF1RCDK2CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898631-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
EP-3897840-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
EP-3898629-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
EP-3897839-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
EP-3898630-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2021-10-27 — — EP disclosed
WO-2020127075-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126954-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126952-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126953-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126956-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
Send feedback